CSIMarket
 


Citius Pharmaceuticals Inc   (CTXR)
Other Ticker:  
 
 

CTXR's Net Cash Flow Growth by Quarter and Year

Citius Pharmaceuticals Inc 's Net Cash Flow results by quarter and year




CTXR Net Cash Flow (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter September - -6.80 -6.33 -45.59
III Quarter June - 4.22 -7.71 11.97
II Quarter March - -7.82 -9.67 99.40
I Quarter December -6.14 -4.82 -4.65 -9.56
FY   -6.14 -15.22 -28.36 56.22



CTXR Net Cash Flow first quarter 2024 Y/Y Growth Comment
Citius Pharmaceuticals Inc in the first quarter 2024 recorded net cash outflow of $ -6.14 millions.

According to the results reported in the first quarter 2024, Citius Pharmaceuticals Inc achieved the best Net Cash Flow growth in Major Pharmaceutical Preparations industry. While Citius Pharmaceuticals Inc ' s Net Cash Flow no change of % ranks overall at the positon no. in the first quarter 2024.




CTXR Net Cash Flow ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter September - - - -
III Quarter June - - - 186.36 %
II Quarter March - - - 6271.79 %
I Quarter December - - - -
FY   - - - 841.71 %

Financial Statements
Citius Pharmaceuticals Inc 's first quarter 2024 Net Cash Flow $ -6.14 millions CTXR's Income Statement
Citius Pharmaceuticals Inc 's first quarter 2023 Net Cash Flow $ -4.82 millions Quarterly CTXR's Income Statement
New: More CTXR's historic Net Cash Flow Growth >>


CTXR Net Cash Flow (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter September - - - -
III Quarter June - - - -87.96 %
II Quarter March - - - -
I Quarter December - - - -
FY (Year on Year)   - - - 841.71 %




Net Cash Flow first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Net Cash Flow first quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Net Cash Flow by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Citius Pharmaceuticals Inc 's Q/Q Net Cash Flow Growth


Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CTXR's I. Quarter Q/Q Net Cash Flow Comment
Despite the fact, that Citius Pharmaceuticals Inc in the I. Quarter 2024 showed net cash outflow of $ -6.14 millions, it should be said, that this are slight up side relative to the -6.80 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Citius Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While Citius Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


CTXR's I. Quarter Q/Q Net Cash Flow Comment
Despite the fact, that Citius Pharmaceuticals Inc in the I. Quarter 2024 showed net cash outflow of $ -6.14 millions, management mentioned, that this point to slight up side compare to the -6.80 millions in the fourth quarter.

Within Major Pharmaceutical Preparations industry Citius Pharmaceuticals Inc achieved highest sequential Net Cash Flow growth. While Citius Pharmaceuticals Inc 's Net Cash Flow growth quarter on quarter, overall rank is .


Citius Pharmaceuticals Inc 's 12 Months Net Cash Flow Growth Year on Year


Net Cash Flow TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Net Cash Flow 12 Months Ending $ -16.54 $ -15.23 $ -14.76 $ -26.69 $ -28.53
Y / Y Net Cash Flow Growth (TTM) - - - - -
Year on Year Net Cash Flow Growth Overall Ranking # # # # #
Seqeuential Net Cash Flow Change (TTM) - - - - -
Seq. Net Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Net Cash Flow growth Comment


Citius Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Net Cash Flow growth Comment


Citius Pharmaceuticals Inc achieved highest trailing twelve month year on year Net Cash Flow growth. While overall Net Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Net Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Net Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Net Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Net Cash Flow Growth
Major Pharmaceutical Preparations Industry Net Cash Flow Growth Trends and Statistics
Healthcare Sector Net Cash Flow Growth Statistics
Net Cash Flow Growth Trends for overall market
CTXR's Net Cash Flow Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Cash Flow Growth
Lowest Ranking Net Cash Flow Growth
Net Cash Flow Growth for CTXR's Competitors
Net Cash Flow Growth for Citius Pharmaceuticals Inc 's Suppliers
Net Cash Flow Growth for CTXR's Customers

You may also want to know
CTXR's Annual Growth Rates CTXR's Profitability Ratios CTXR's Asset Turnover Ratio CTXR's Dividend Growth
CTXR's Roe CTXR's Valuation Ratios CTXR's Financial Strength Ratios CTXR's Dividend Payout Ratio
CTXR's Roa CTXR's Inventory Turnover Ratio CTXR's Growth Rates CTXR's Dividend Comparisons



Companies with similar Net Cash Flow no change for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Net Cash Flow for the quarter ending Dec 31 2023
Corcept Therapeutics Inc47.65%$ 47.650 millions
Agios Pharmaceuticals Inc 42.01%$ 42.011 millions
Chemed Corporation36.87%$ 36.872 millions
Organon and Co 34.78%$ 34.783 millions
Inmed Pharmaceuticals Inc 33.04%$ 33.036 millions
Eterna Therapeutics Inc 32.23%$ 32.226 millions
Immutep Limited32.02%$ 32.020 millions
Celldex Therapeutics inc 26.13%$ 26.129 millions
Sanofi26.12%$ 26.124 millions
Molecular Partners Ag22.47%$ 22.465 millions
Diamedica Therapeutics Inc 18.09%$ 18.089 millions
Bionomics Limited17.77%$ 17.774 millions
Perrigo Company Plc15.91%$ 15.909 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com